Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Peijia Medical Announces First Chinese Patient Implanted with TaurusTrio™ Transcatheter Aortic Valve Replacement System 2023-08-01 20:00
Chinese Patent Granted for A*STAR Spinoff, CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell Technology 2023-08-01 19:00
Doer Biologics Announces First Subject Dosed in Phase I 12-Week Multiple-Ascending Dose (MAD) Clinical Trial of DR10624 and Received IND Approval From NMPA 2023-08-01 17:08
Everest Medicines Announces Completion of Patient Enrollment in Nefecon® China Open Label Extension Study 2023-08-01 08:47
FDA Clears Numares Health Cardiovascular Diagnostic Test and Core Technology Platform 2023-08-01 01:11
Hybribio showcased cutting-edge cervical cancer HPV diagnostic solutions at ADLM 2023 2023-08-01 01:00
Transforming Personal Trials into Triumphs: Project M.A.T.T.Y. Pioneers AI-Driven Autism and ADHD Support 2023-08-01 00:15
Seegene unveils solutions to popularize molecular diagnostics at 2023 AACC 2023-08-01 00:00
Fosun Health Capital reached a cooperation agreement with Medicilon to explore innovative drug research and development together 2023-07-31 20:30
WuXi AppTec Announced Strong Results of the Second Quarter and First Half of 2023, on Top of an Exceptionally Strong Year in 2022 2023-07-31 18:02
111 to Announce Second Quarter 2023 Unaudited Financial Results on August 24, 2023 - Conference Call to Follow 2023-07-31 17:59
Biosion Announces Phase II Study Start for Anti-TSLP mAb BSI-045B in Atopic Dermatitis (ADAMANT) 2023-07-31 17:05
GLOBAL SARCOMA THERAPY NOW LISTED ON PHARMACEUTICAL BENEFITS SCHEME 2023-07-31 15:00
U.S. FDA Accepts Biologics License Application for GC Biopharma's GC5107B (Immune Globulin Intravenous (Human), 10% Liquid) 2023-07-31 13:20
J INTS BIO, Novel Oral 4th Generation EGFR TKI 'JIN-A02' - Dosing of First Patient in the Global Multi-center Phase 1/2 Clinical Study began 2023-07-31 13:10
Akeso Inc. Published 2023 Interim Results Positive Profit Alert 2023-07-31 12:33
NMPA and FDA Approved the First-in-Human Clinical Trial Applications to Evaluate LBL-034, An Anti-GPRC5D/CD3 Bispecific Antibody Developed by Leads Biolabs, in Relapsed/Refractory Multiple Myeloma 2023-07-31 12:09
Transcenta Anti-sclerostin Monoclonal Antibody TST002 (Blosozumab) Received Approval from China CDE to Initiate Phase II Clinical Trial in Patients with Reduced Bone Mineral Density 2023-07-31 08:10
Daewoong Pharmaceutical submits a new drug application for Fexuprazan in China challenging the world's largest market for anti-ulcer drugs 2023-07-31 08:00
Yodaplus: Shaping the Future of Industries with Powerful AI Integration 2023-07-31 07:30
1 170 171 172 173 174 970